Health
Discoverey of four SARS-CoV-2 Mpro inhibitors, boceprevir, calpain inhibitors II and XII and GC-376 – News-Medical.Net
A team of scientists from the United States has recently revealed that small molecule inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
A team of scientists from the United States has recently revealed that small molecule inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease exhibit potent antiviral activity. These inhibitors show better efficacy when used in combination with antiviral medicine Remdesivir. The study is currently available on the bioRxiv* preprint server.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19) pandemic,…
-
Business7 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Business23 hours agoUS markets swung wildly last night. How extreme volatility can be a gift to ASX investors
-
Noosa News20 hours agoWatch desert floodwaters gushing towards Lake Eyre
-
Noosa News22 hours agoMajor flood arrives at Birdsville